HKD 7.83
(-6.23%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 25.11 Million CNY | -29.47% |
2022 | 35.6 Million CNY | -20.77% |
2021 | 44.94 Million CNY | -97.39% |
2020 | 1.71 Billion CNY | 49004.37% |
2019 | 3.5 Million CNY | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | - CNY | 0.0% |
2024 Q1 | - CNY | 0.0% |
2023 FY | 25.11 Million CNY | -29.47% |
2023 Q2 | 30.54 Million CNY | 0.0% |
2023 Q1 | 30.54 Million CNY | -14.22% |
2023 Q4 | 25.11 Million CNY | 0.0% |
2023 Q3 | 25.11 Million CNY | -17.78% |
2022 Q2 | 40.31 Million CNY | 0.0% |
2022 Q1 | 40.31 Million CNY | -10.29% |
2022 FY | 35.6 Million CNY | -20.77% |
2022 Q4 | 35.6 Million CNY | 0.0% |
2022 Q3 | 35.6 Million CNY | -11.68% |
2021 Q2 | - CNY | -100.0% |
2021 FY | 44.94 Million CNY | -97.39% |
2021 Q1 | 2.6 Billion CNY | 0.0% |
2021 Q4 | 44.94 Million CNY | 0.0% |
2021 Q3 | 44.94 Million CNY | 0.0% |
2020 FY | 1.71 Billion CNY | 49004.37% |
2020 Q1 | - CNY | 0.0% |
2019 FY | 3.5 Million CNY | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Uni-Bio Science Group Limited | 30.61 Million HKD | 17.96% |
CK Life Sciences Int'l., (Holdings) Inc. | 4.27 Billion HKD | 99.412% |